FOLD FY 2015 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

FOLDAmicus Therapeutics, Inc.

$5B

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$2M

Operating Income

-$130M

Net Income

-$132M

EPS (Diluted)

$-1.20

Cash Flow

Operating Cash Flow

-$100M

Free Cash Flow

-$105M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$908M

Total Liabilities

$561M

Stockholders' Equity

$348M

Cash & Equivalents

$69M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$1M	-100.0%
Gross Profit	-$2M	$1M	-249.8%
Operating Income	-$130M	-$69M	-89.9%
Net Income	-$132M	-$69M	-91.7%